Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation
S Gabardi, SS Waikar, S Martin, K Roberts… - Clinical Journal of the …, 2010 - journals.lww.com
Background and objectives: Nearly 30% of renal transplant recipients develops BK viremia,
a prerequisite for BK nephropathy. Case reports have evaluated treatment options for BK
virus, but no controlled studies have assessed prophylactic therapies. Fluoroquinolone
antibiotics were studied for prevention of BK viremia after renal transplantation.
a prerequisite for BK nephropathy. Case reports have evaluated treatment options for BK
virus, but no controlled studies have assessed prophylactic therapies. Fluoroquinolone
antibiotics were studied for prevention of BK viremia after renal transplantation.